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1. Introduction 
Proper gonadal function in mammals depends on gonadotropins secreted from the pituitary 
gland in a pulsatile manner. The hypothalamus, in turn, controls the secretion of 
gonadotropins by the pulsatile secretion of gonadotropin releasing hormone (GnRH) into 
the portal circulation of the pituitary. The idea of brain control over the hypophysis was first 
postulated by Geoffrey Harris during the late 1940s and early 1950s (Harris, 1948). The 
evidence available at that time indicated that stimulation of the central nervous system, but 
not direct stimulation of the pars distalis or neural lobe, caused the release of 
adenohypophysial hormones. During the 1950s and 1960s, trophic substances were 
extracted from the brain of different species (Guillemin, 2005). These releasing factors 
obtained from the median eminence affected secretions of the pars distalis. The search for 
these releasing factors was lead by McCann, Schally and Guillemin (Guillemin and 
Rosenberg, 1955; McCann and Fruit, 1957; Rumsfeld and Porter, 1962; Saffran et al., 1955). 
Andrew Schally and his team isolated and synthesized for the first time the decapeptide 
GnRH, after the extraction of more than 250,000 pig hypothalami (Matsuo et al., 1971; Wade, 
1978). Initially Schally and coworkers postulated that one hypothalamic hormone LH-
RH/FSH-RH or simply GnRH controls the secretion of both LH and FSH from the pituitary 
gland (Schally et al., 1971). The terms luteinizing hormone-releasing hormone, and 
gonadotropin-releasing hormone have been widely adopted, and most journals allow the 
use of both names and abbreviations (Schally, 2000). In addition to GnRH, the occurrence of 
other two GnRH isoforms was first reported in chickens more than 10 years after of Dr. 
Schally’s initial report (King and Millar, 1982; Miyamoto et al., 1982; Miyamoto et al., 1984). 
To date, several structural variants of GnRH have been identified in diverse vertebrates 
(Barran et al., 2005; Millar et al., 2004). These isoforms have various functions, including 
paracrine, autocrine, neuroendocrine, and neurotransmitter/neuromodulatory roles in the 
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central and peripheral nervous systems (King and Millar, 1995; Millar and King, 1987; 
Sealfon et al., 1997; Skinner et al., 2009).  
 1 2 3 4 5 6 7 8 9 10 
Mammal (mGnRH) pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly 
 
Chicken-I (cGnRH-I) pGlu-His-Trp-Ser-Tyr-Gly-Leu-Gln-Pro-Gly 
 
Chicken-II (cGnRH-II) pGlu-His-Trp-Ser-His-Gly-Trp-Tyr-Pro- Gly 
 
Lamprey-III (lGnRH-III) pGlu-His-Trp-Ser-His-Asp-Trp-Lys-Pro-Gly 
Table 1. Amino acid (AA) sequence of GnRH isoforms. The bolded regions represent the conserved 
NH3- and COOH- terminal residues. The numbers represent the relative position of each AA in the 
GnRH peptide (1 represents the N-terminal AA) 
The nomenclature used to distinguish different GnRH isoforms between mammalian and 
non-mammalian species have been described using a variety of phylogenic and genomic 
synteny analyses (Kim et al., 2011; Millar et al., 2004; Roch et al., 2011; Tostivint, 2011). For 
the purpose of this book chapter, we adopted the nomenclature based on the species in 
which they were first discovered, depicted in Table 1, and described elsewhere (Millar et al., 
2004). 
In addition to the classically described mammalian form of GnRH (for extensive review see 
(Barb et al., 2001; Clarke, 2002; Esbenshade et al., 1990; Kaiser et al., 1997; McCann et al., 
2002; Millar, 2005; Millar et al., 2008)), chicken GnRH-II (cGnRH-II) and lamprey GnRH-III 
(lGnRH-III) are of particular significance because they may coordinate the control of LH and 
FSH secretion in some vertebrate species.  
2. GnRH receptors 
The coordination of gonadotropin secretion is also modulated by the interaction of the 
GnRH peptide with its receptors. The GnRH receptor (GnRHR) has the characteristic feature 
of a classical seven-transmembrane G-protein-coupled receptor (Millar, 2003, 2005; Neill, 
2002). Four vertebrate GnRHR lineages have been proposed using genome synteny and 
phylogenic analyses; nonmammalian type I, nonmammalian type II, nonmammalian type 
III/mammalian type II, and mammalian type I (Kim et al., 2011). For the purpose of this 
book chapter, we refer to the type I and type II GnRHRs as the mammalian type I and 
mammalian type II GnRH receptor, respectively.  
There is evidence that in the rhesus monkey (Macaca mulatta) and the marmoset (Callithrix 
jacchus), the type I GnRHR has high affinity for mGnRH and lower affinity for cGnRH-II, 
and the type II GnRHR has high affinity for cGnRH-II and lower affinity for mGnRH (Millar 
et al., 2001; Neill, 2002). In fact, when COS-1 or COS-7 cells were transfected with the type II 
GnRHR, the potency was high for cGnRH-II and low for mGnRH. Nonetheless, in vivo and 
in vitro work in rhesus monkey (Densmore and Urbanski, 2003; Okada et al., 2003) and pigs 
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(Neill et al., 2002), using specific type I GnRHR antagonists (Antide and Cetrorelix) suggest 
that cGnRH-II can also stimulate gonadotropin secretion via the type I GnRHR (Neill et al., 
2004).  
 
 
Figure 1. Concentrations of the type I GnRHR (A) and expression of the mRNA for the type I GnRHR 
(B) in the pituitary gland of anestrous cows that were treated for 13 days with 2 µg of mGnRH infused 
(i.v.) continuously during 1 h (mGnRH-C), during 5 min once every hour (mGnRH-1), or during 5 min 
once every fourth hour (mGnRH-4) or with saline (control).  Different letters indicate significant 
differences (P < 0.1 for A and P< 0.05 for B).  Adapted from (Vizcarra et al., 1997). 
In the pig, as well as other mammals, type I GnRHRs are characterized by the absence of a 
carboxyl-terminal tail (Kakar et al., 1992; Millar et al., 2004; Neill et al., 2004; Tsutsumi et al., 
1992; Weesner and Matteri, 1994). The tail-less type I GnRHR is associated with a resistance 
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to rapid desensitization and ligand-induced internalization (Blomenrohr et al., 1999). When 
COS-1 cells expressing the type I receptor were incubated with a maximal dose of a mGnRH 
agonist, [3H]-inositol phosphate (IP) accumulated for 90 min indicating the failure of mGnRH 
desensitization during the experimental period (Neill, 2002). From a practical standpoint, we 
have demonstrated that administration of mGnRH at different frequencies differentially 
regulates the concentrations and the expression of the type I GnRHR (Vizcarra et al., 1997). 
Concentrations and expression of the type I GnRHR were reduced when mGnRH was infused 
continuously compared with those in control cows (Figure 1). However, when mGnRH was 
given as a pulse every hour or every fourth hour, concentration and expression of the type I 
GnRHR were not different from those in control cows. Our data indicates that pulsatile 
mGnRH does not influence concentrations of the type I GnRHR or type I GnRHR mRNA, but 
continuous infusion of mGnRH dramatically reduces the concentrations and expression of the 
type I GnRHR in the pituitary gland (Vizcarra et al., 1997). 
The type II GnRHR has only 41% identity with the type I receptor and in contrast to the type 
I GnRHR, the type II receptor has a C-terminal cytoplasmic tail that is important for cell 
surface expression and agonist binding. The type II GnRHR has been cloned in several 
vertebrate species; whereas the type I GnRHR has been identified only in mammals (Kim et 
al., 2011). The tail of the type II GnRHR is phosphorylated upon agonist-binding followed 
by internalization and desensitization of the receptor (Blomenrohr et al., 1999). As with the 
type I receptor, the type II couples to the Gqα protein and, consequently, mediates the 
intracellular production of inositol trisphosphate (Cabrera-Vera et al., 2003; Millar and 
Newton, 2010). In contrast to the type I GnRHR, desensitization of the type II GnRHR in 
rhesus monkeys takes about 60 minutes, reflecting the properties of the cytoplasmic tail 
(Neill, 2002).  
3. Chicken GnRH-II 
Phylogenic evidence indicates that cGnRH-II (initially isolated from the chicken brain) is an 
ancient form of GnRH that has been structurally conserved for over 100 million years of 
evolution, suggesting that its neural functions may have an important significance (Powell 
et al., 1994; Rastogi et al., 1998).  
In birds, two forms of GnRH (cGnRH-I and cGnRH-II; Table 1) have been reported (King 
and Millar, 1982; Miyamoto et al., 1982; Miyamoto et al., 1984) and only indirect 
measurements of the GnRH pulse generator is available by measuring plasma LH 
concentrations in frequent samples or in pituitary extracts (Chou and Johnson, 1987; Sharp 
and Gow, 1983; Wilson and Sharp, 1975). In addition, we have reported the episodic nature 
of gonadotropin secretion in the mature fowl (Vizcarra et al., 2004). Gonadotropin secretion 
in chickens is characterized by a pulsatile pattern with LH pulses being more frequent and 
having greater amplitude than FSH pulses (Figure 2). Furthermore, we observed that there 
was a lack of synchrony between the episodic release of LH and FSH. Only 23% of the LH 
pulses were associated with FSH episodes, suggesting that in the adult male fowl LH and 
FSH secretion are regulated independently (Vizcarra et al., 2004). 
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Figure 2. Pulsatile secretion of LH and FSH in plasma of four birds. Blood samples were obtained every 
10-min for 8 h. Asterisks indicate the presence of a pulse of LH or FSH, as determined by Pulsar.  
Adapted from (Vizcarra et al., 2004) 
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Both cGnRH-I and -II stimulates gonadotropin release in vivo and in vitro in the chicken 
(Hattori et al., 1986). However, cGnRH-II was not found in the median eminence of the 
white-crowned sparrow (Zonotrichia leucophrys gambelii), suggesting that in these species 
cGnRH-II does not regulate pituitary gonadotropin secretion (Meddle et al., 2006). Although 
concentrations of FSH in small cockerels were not affected by cGnRH-I challenge (Krishnan 
et al., 1993), most of the evidence indicates that cGnRH-I is the prime regulator of 
gonadotropin release in chickens (Katz et al., 1990; Sharp et al., 1990). Active immunization 
against cGnRH-I but not against cGnRH-II was associated with decreased concentration of 
LH in laying hens (Sharp et al., 1990). We also evaluated the effect of active immunization 
against cGnRH-I and cGnRH-II in adult broiler breeder males (Vizcarra et al., 2000). At 10 
weeks of age, males (10 per treatment), received a primary immunization against cGnRH-I, 
cGnRH-II, BSA, or were not immunized. Peptides were conjugated to BSA and emulsified in 
Freund’s incomplete adjuvant and diethylaminoethyl-dextran. Booster immunizations were 
given at 3, 6 and 14 weeks after the primary immunization. Titers were increased in cGnRH-
I but not in cGnRH-II treated birds compared with BSA immunized males (Figure 3). 
Concentrations of LH and FSH in frequent samples were not affected by treatment; 
however, testis weight was significantly decreased in cGnRH-I birds compared to the other 
treatments (Figure 4).  
 
Figure 3. Antibody titers of male broiler breeders immunized against cGnRH-I, cGnRH-II, and BSA.  
Titers were increased (P < 0.05) in cGnRH-I but not in cGnRH-II treated birds compared with BSA 
immunized males.   
There is evidence of a behavioral role attributed to cGnRH-II in birds that may be 
independent from cGnRH-I. Intracerebroventricular (ICV) infusion of cGnRH-II induced 
copulation solicitation in the female white-crowned sparrow, and social interactions in the 
house sparrow (Passer domesticus) may be regulated by cGnRH-II (Maney et al., 1997; 
Stevenson et al., 2008). In the mature male Zebra finch (Taeniopygia guttata) the number of 
cGnRH-II neurons is significantly reduced during the non-breeding season as compared 
with the breeding season (Perfito et al., 2011). A similar behavioral role of cGnRH-II has 
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been reported in mice (Kauffman and Rissman, 2004a). However, this information is 
questionable due to the lack of a functional cGnRH-II peptide and the lack of a functional 
type II GnRHR in mice (Stewart et al., 2009). 
 
Figure 4. Testis weight of male broiler breeders immunized against cGnRH-I, cGnRH-II, BSA, and not 
immunized (Control) birds.  Different letters indicate significant differences (P < 0.05) 
Among primates, the rhesus monkey (Macaca mulatta), is one of the few species studied to 
date that posses a functional cGnRH-II peptide and type II GnRHR (Stewart et al., 2009). In 
these species, cGnRH-II is expressed in the hypothalamic median eminence (Urbanski et al., 
1999), and has the ability to stimulate gonadotropin secretion (Lescheid et al., 1997). The 
rhesus hypothalamic cells that express mGnRH and cGnRH-II have a differential 
distribution pattern. In contrast to mGnRH, the axonal projections of cGnRH-II have a direct 
input in the neural lobe of the pituitary gland, raising the possibility that both forms of 
GnRH may play different physiological roles in the regulation of gonadotropin secretion 
(Urbanski et al., 1999). When cultured pituitary cells form male rhesus monkeys were 
incubated with cGnRH-II, LH and FSH were significantly increased. However, the in vitro 
effect of cGnRH-II on gonadotropin secretion was less potent than that of mGnRH (Okada et 
al., 2003). In contrast, in vivo exogenous doses of mGnRH and cGnRH-II in female rhesus 
monkeys were equally potent at stimulating LH release with little effect on FSH secretion 
(Densmore and Urbanski, 2003). In males and females rhesus monkeys, cGnRH-II mRNA 
expression in the mediobasal hypothalamus (MBH) significantly increased in adult animals 
compared with prepubertal macaques (Latimer et al., 2001). Since the MBH is associated 
with the pre-ovulatory LH surge and overall reproductive development (Spies et al., 1977), 
it is possible that cGnRH-II may play a role in the onset of puberty and sexual behavior. 
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Estrogen significantly increases cGnRH-II expression in the MBA (Densmore and Urbanski, 
2004), while the same steroid significantly decreases mGnRH expression (Densmore and 
Urbanski, 2004; El Majdoubi et al., 1998). The positive and negative feedback mechanism of 
estrogen on the reproductive axis may be explained by the presence of the two GnRH 
isoforms present in the brain of the rhesus monkey. As noted above, few primate species are 
known to possess a functional cGnRH-II peptide and associated type II GnRH receptor. For 
instance, in the Chimpanzee (Pan troglodytes) the genes encoding the cGnRH-II peptide and 
the type II GnRH receptor contains a premature stop codon (Ikemoto and Park, 2006; 
Stewart et al., 2009); therefore there is a disruption of the ligand and the receptor. 
Information on regard to the GnRH-II system obtained in the rhesus monkey should not be 
generalized to other primate species.  
Although human posses a functional cGnRH-II peptide, the type II GnRH receptor is 
disrupted by a frame shift and premature stop codon (Pawson et al., 2005). The type II 
GnRHR gene remains active and an alternative splicing (GnRHR-II-reliquum) is expressed 
in gonadotropes that contains the type I GnRHR (Millar et al., 1999; Pawson et al., 2005). 
Simultaneous transfection of the type I GnRHR and GnRHR-II-reliquum into COS-7 cells 
resulted in reduced expression of the type I GnRHR, suggesting a modulator role of the 
GnRHR-II reliquum on the type I GnRH receptor (Pawson et al., 2005). 
In the Musk shrew (Suncus murinus), cGnRH-II was identified by HPLC and 
radioimmunoassay (RIA), and the presence of a functional peptide subsequently reported 
(Dellovade et al., 1993; Rissman and Li, 1998; Stewart et al., 2009). Although there is 
evidence that the type II GnRHR may mediate behavioral effects of cGnRH-II in the Musk 
shrew (Kauffman et al., 2005), a functional type II GnRHR has not been reported (Stewart et 
al., 2009). Nevertheless, ICV infusion of cGnRH-II but not mGnRH stimulated sexual 
behavior in nutritionally challenged female musk shrews (Temple et al., 2003). When musk 
shrews were exposed to different levels of caloric intake, cGnRH-II mRNA expression was 
modulated by feed intake (Kauffman et al., 2006; Kauffman and Rissman, 2004b). These data 
suggest a role of GnRH-II in both feeding and sexual behavior. 
Among domestic animals, the pig is the only relevant livestock species that expresses both a 
functional mGnRH and cGnRH-II peptide and the associated cognate functional type I and 
type II GnRHR (Stewart et al., 2009). In bovine and ovine species the cGnRH-II peptide and 
the type II GnRHR receptor are functionally inactivated (Morgan et al., 2006) and in equine 
species, the type II GnRHR is functionally inactivated (Stewart et al., 2009).  
Very little information on the effect of cGnRH-II on gonadotropin secretion is available in 
pigs. Treatment of pig pituitary cells with nanomolar concentrations of cGnRH-II 
consistently stimulated a 15-20 fold increase in LH secretion, while FSH secretion was more 
variable, ranging from none to a 4-fold stimulation (Neill et al., 2002).  
We conducted studies to evaluate the effect of active immunization against cGnRH-II on 
gonadotropin secretion and testicular function in boars (Bowen et al., 2006). A synthetic 
cGnRH-II peptide, where the common pGlu-His-Trp-Ser sequence at the N-terminal was 
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suppressed (see table 1) and a Cys residue was incorporated, was used in the conjugation 
process. Antibody titers were detectable in GnRH-II immunized animals four weeks after 
primary immunization (bottom panel Figure 5). Titers continued to increase as booster 
immunizations were given with limited to no cross-reactivity between mGnRH and cGnRH-
II. No mGnRH specific antibodies were detected in control animals. Antibody titers against 
mGnRH were measured to determine if cGnRH-II antibodies recognized mGnRH. None of 
the animals produced antibodies that recognized mGnRH. However, when a plasma sample 
from a cow previously immunized against mGnRH was used, antibody titers were 
significantly higher (Figure 5; inset upper panel). None of the animals produced antibodies 
that recognized mGnRH, indicating that animals immunized against cGnRH-II produced 
antibodies that recognized only their own specific amino acid sequence. Active 
immunization against cGnRH-II significantly decreased gonadotropin secretion when 
compared with control barrows (Figure 6). These data suggest that the two GnRHs and 
GnRHRs systems, along with differences in signaling pathways, provide the potential for 
differential gonadotropin secretion in pigs.  
GnRH antagonists, of which thousands have been formulated, cause an immediate and 
rapid reversible suppression of gonadotropin secretion. The principal mechanism of action 
of GnRH antagonists is competitive receptor occupancy of GnRHRs (Herbst, 2003; Huirne 
and Lambalk, 2001). The first generation of mGnRH antagonists contained replacements for 
His at position 2 and for Trp at position 3 (Huirne and Lambalk, 2001). The inhibitory 
activity increased after incorporation of a D-amino acid at position 6, but increased 
histamine-releasing activity resulted in anaphylactic reactions. The third generation 
antagonists have low histamine-releasing potency by replacing the D-amino acid at position 
6 by neutral D-ureidoalkyl amino acids (Huirne and Lambalk, 2001). In pigs a third-
generation antagonist (Cetrorelix) has been used in vivo and in vitro (Neill, 2002; Zanella et 
al., 2000). The ability of cetrorelix to inhibit [3H]-IP accumulation in response to cGnRH-II 
was evaluated in COS-1 cells that were transfected with the type II GnRHR. Increased 
concentrations of cGnRH-II in the media resulted in no inhibition of IP, and when cetrorelix 
was tested for agonist activity with the type II GnRHR, no activity was observed even at 
large doses (Neill, 2002). These data suggest that cetrorelix is a potent and specific 
antagonist to the type I GnRH receptor.  
Daily intramuscular (i.m.) doses of cetrorelix decreased gonadotropin secretion in intact and 
castrated boars and gilts (Wise et al., 2000; Zanella et al., 2000; Ziecik et al., 1989). 
Administration of low doses (5 µg/kg of body weight; BW) of cetrorelix resulted in a decline 
of LH but had no effect on FSH concentrations, while doses of 10 µg/kg BW of cetrorelix 
were sufficient to inhibit FSH secretion (Wise et al., 2000; Zanella et al., 2000). Larger doses 
(20 µg, 50 µg, and 1 mg/kg BW) of cetrorelix also resulted in a significant decrease in LH 
concentrations with varied responses in FSH secretion (Moran et al., 2002; Wise et al., 2000; 
Ziecik et al., 1989). The lack of a consistent reduction of FSH secretion in pigs treated with 
the type I GnRHR antagonist may be associated with the presence of two GnRHs and two 
GnRH receptors, together with the differences in their signaling in swine species.  
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Figure 5. Effect of immunization on antibody titers against mGnRH and cGnRH-II in control barrows 
and boars immunized against BSA, and intact pigs immunized against cGnRH-II (n = 12/treatment).  
Antibody titers increased in animal immunized against cGnRH-II after the first booster immunization.  
Arrows indicate the times at which primary (P) and booster (B) immunizations were given.  Plasma 
from a cow previously immunized against mGnRH (Vizcarra et al., 2011) was used as a positive control 
(inset).  Adapted from (Bowen et al., 2006). 
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Figure 6. Concentrations of LH and FSH in weekly samples of control barrows and boars immunized 
against BSA, and intact pigs immunized against cGnRH-II (n= 12/treatment).  There was a treatment 
effect for LH (P < 0.01) and a treatment x week interaction for FSH (P < 0.03), resulting in gonadotropin 
concentrations that were greater in control barrows compared with boars and cGnRH-II pigs.  Arrows 
indicate the time at which primary (P) and booster (B) immunizations were given.  Adapted from 
(Bowen et al., 2006). 
Antagonist for the type II GnRHR have also been developed and tested in cells expressing 
rat GnRH (Maiti et al., 2003), human endometrial cells (Fister et al., 2007), and mice (Kim et 
al., 2009). However, all of these species have lost a functional type II GnRHR (Stewart et al., 
2009) and data from these experiments are questionable. A type II GnRHR knockdown 
swine is being developed (Desaulniers et al., 2011). This animal model may provide new 
cues on the relative contribution of the type II GnRHR in pigs. 
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Taken together, GnRH-II is the most ancient and conserved member of the GnRH family, it 
is expressed in several vertebrates, and has the ability to control gonadotropin secretion in 
species that have a functional GnRH-II and type II GnRHR.  
4. Lamprey GnRH-III 
Sower and coworkers (Sower et al., 1993), reported the isolation of lGnRH-III from the sea 
lamprey (Petromyzon marinus). Although lGnRH-III is not a natural ligand of the type I or 
type II GnRHR, the lGnRH-III receptor shares different characteristics of both type I and 
type II GnRHRs (Silver et al., 2005; Silver and Sower, 2006). The presence of lGnRH-III (or a 
related analog) have been reported in brain extracts from humans, sheep, cows and rats 
(Dees et al., 1999; Hiney et al., 2002; Yahalom et al., 1999; Yu et al., 2000), suggesting a 
biological activity of this GnRH isoform in several species. However, to date, the gene 
expression of lGnRH-III has not been reported in mammalian species. There are indications 
that lGnRH-III might have antiproliferative effects on different types of cancer. Several 
GnRH analogs are used to treat various forms of cancer (Schally et al., 2001). Among these 
isoforms, lGnRH-III has a substantial antiproliferative effect on several cancer cell lines 
(Heredi-Szabo et al., 2006; Lovas et al., 1998; Mezo et al., 1997; Palyi et al., 1999),  
The physiologic role played by lGnRH-III on gonadotropin secretion in mammalian species 
is controversial. Although lGnRH-III is a weak GnRH agonist, early research in mammalian 
species suggested that lGnRH-III can selectively stimulate the secretion of FSH without 
changing concentration of LH.  
In rodents, lGnRH-III significantly increased FSH concentrations in a dose-dependent 
manner when using anterior pituitaries at 10-9 to 10-4 M concentrations. In contrast, LH 
concentrations were affected only when the highest doses of lGnRH-III (10-6 to 10-4 M) were 
used (Yu et al., 1997). Intravenous (i.v.) infusion of lGnRH-III also increased FSH without 
changes in LH concentrations (Yu et al., 1997). Subsequently, data from the same laboratory 
reported the isolation of a FSH-releasing factor (RF) obtained from the stalk-median 
eminence of rats. The FSHRF was associated with lGnRH-III, and had the ability to interact 
with a putative receptor to selectively release FSH (McCann et al., 2001; Yu et al., 2002; Yu et 
al., 2000). These data and that from other non-traditional sources (McCann and Yu, 2001) 
suggest that lGnRH-III is a potent and specific FSH-releasing peptide. However, other lines 
of research have raised questions about the ability of lGnRH-III to selectively secrete FSH in 
rodents (see below). 
The presence of lGnRH-III in the brain of rats was identified by immunocytochemistry 
(Dees et al., 1999), and subsequently localized in the dorsomedial preoptic area (POA) of the 
brain and colocalized with mGnRH (Hiney et al., 2002). However, lGnRH-III was not 
detected in rats and other rodents by reverse-phase-HPLC followed by RIA, or by 
performing two successive HPLC steps to prevent the coelution of GnRH peptides (Gautron 
et al., 2005; Montaner et al., 1999; Montaner et al., 2001). When rats were infused (i.v.) with 
doses of lGnRH-III or mGnRH, gonadotropin secretion was increased in a dose-dependent 
manner with a greater increase in LH than FSH concentrations. The potency of lGnRH-III 
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was 180 to 650 fold weaker than that of mGnRH (Kovacs et al., 2002). Similarly, when rat 
pituitary cells were perfused with lGnRH-III or mGnRH (10-9 to 10-6 M), lGnRH-III was 1,000 
fold less active in releasing LH than mGnRH (Lovas et al., 1998). Moreover, when rat 
pituitary cells were perfused with doses (10-7 to 10-5 M) of lGnRH-III, gonadotropin secretion 
was increased without any indication of a selective secretion of FSH (Kovacs et al., 2002). 
These data is in agreement with in vitro results obtained from rat hemipituitaries incubated 
with doses (10-9 to 10-7 M) of lGnRH-III (Montaner et al., 2001). The contradictory results 
obtained by different laboratories, may be explained by experimental condition, the 
influence of the presence or absence of steroid in the in vivo models, and data interpretation 
(Kovacs et al., 2002).  
Undoubtedly, more research is needed to clarify the existence of lGnRH-III or a FSHRF that 
may be involved in the differential secretion of gonadotropins in mammals. In addition to 
the information provided above, other areas of investigation have stressed the need to 
reconsider the traditional conjecture that a single GnRH molecule controls reproduction 
(Igarashi and McCann, 1964; McCann et al., 1983; Padmanabhan and McNeilly, 2001). 
Briefly, lesions to the median eminence (ME) of castrated male rats suppressed LH but not 
FSH pulses, while animals with posterior to mid-ME lesions had no FSH pulses but 
maintained LH episodic releases (Marubayashi et al., 1999). Similarly, ablation of the dorsal 
anterior hypothalamus of ovariectomized rats suppressed FSH pulses but not LH (Lumpkin 
et al., 1989). These results raise the possibility that another form of GnRH may contribute 
nontraditionally to the control of reproductive function or may take part in an important 
neuroendocrine role. The nature of episodic FSH secretion in portal blood cannot be 
accounted completely by changes in GnRH secretion (Padmanabhan et al., 1997). When 
male rats were administered GnRH antiserum and/or GnRH antagonists, pulsatile FSH 
release was maintained while LH was abolished, giving further credence to the view that 
reproductive function may be regulated by more than one GnRH neuronal system (Culler 
and Negro-Vilar, 1987). We have observed that GnRH pulse frequency and amplitude 
differentially regulates LH and FSH gene transcription and serum concentrations of LH and 
FSH in cattle (Vizcarra et al., 1997). However, this mechanism of FSH secretion does not 
preclude the existence of other GnRH releasing factors. It is also possible that the concerted 
action of local pituitary factors and peripheral steroids could lead to a pulsatile FSH pattern. 
For instance activins, inhibins, and follistatins may provide an autocrine-paracrine 
regulation of FSH release at the pituitary level (Baird et al., 1991; DePaolo et al., 1991; 
Mather et al., 1992; Nett et al., 2002; Padmanabhan et al., 2002; Padmanabhan et al., 1997; 
Padmanabhan and McNeilly, 2001).  
Data obtained in the late 1990’s, using the rat model, inspired other laboratories to 
investigate the use of lGnRH-III in domestic species. Since this peptide was able to 
selectively stimulate FSH secretion in rats, several researches evaluated the potential use of 
lGnRH-III in different livestock species. Using similar techniques as those reported in rats, 
lGnRH-III (or a closely related peptide), was also extracted from sheep stalk-median 
eminence using a Sephadex G-25 column (Lumpkin et al., 1987; Yu et al., 2000), and from 
bovine brain samples using HPLC (Yahalom et al., 1999). However, as noted above, the gene 
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expression of lGnRH-III has not been reported in mammalian species. The ability of lGnRH-III 
(obtained from bovine midbrain tissue) to release LH was evaluated in cultured rat pituitary 
cells. The potency of lGnRH-III was only about 2% of that of mGnRH, suggesting that lGnRH-
III is a weak agonist of mGnRH (Yahalom et al., 1999). When lGnRH-III (0.25 and 0.5 mg) was 
infused (i.v.) during the luteal phase of the estrous cycle of crossbred heifers, FSH 
concentrations were increased without changes in LH concentrations. At higher doses (2.0 and 
8.0 mg) both FSH and LH were increased compared with basal concentrations. In contrast, a 
dose of 0.5 mg of lGnRH-III elicited a significant increase in LH with no changes in FSH 
secretion at day 20 of the estrous cycle. Authors suggested that the selectivity of lGnRH-III in 
cattle depends on the dosage and the stage of the estrous cycle (Dees et al., 2001).  
In sharp contrast to the observations described above, no differential gonadotropin secretion 
was reported in ovariectomized cows (exposed to different steroid replacement therapy) 
when infused with doses (0.055, to 1.1 mg/kg BW) of lGnRH-III. Higher doses (4.4 mg/kg 
BW) released LH but not FSH. Similarly, in vitro doses (10-7 to 10-6 M) of lGnRH-III elicited a 
non-selective increase of LH and FSH, while lower doses (10-9 to 10-8 M) were not associated 
with gonadotropin secretion in bovine adenohypophyseal cells (Amstalden et al., 2004).  
A clear and unbiased interpretation of the discordant results observed in cattle (Amstalden 
et al., 2004; Dees et al., 2001) is difficult. Reagents (RIAs) used in both laboratories to 
evaluate LH and FSH were provided by the National Hormone and Pituitary Program. 
Thus, it is unlikely that differences can be attributed to the ability of a particular RIA to 
detect FSH concentrations (Amstalden et al., 2004). The ovariectomized cow model, with 
estradiol and progesterone replacement therapy, used in one experiment (Amstalden et al., 
2004) may provide a better animal model compared with intact cows. As noted above, it is 
well established that ovarian follicular peptides such as actvin, inhibin and follistain 
regulate FSH secretion; therefore, intact animals could be influenced by ovarian secretions 
that may act as a confounding factor. 
Along the same lines described for rats and cattle, there is contradictory evidence on the 
involvement of lGnRH-III on gonadotropin secretion in pigs. Infusion (i.m.) of lGnRH-III in 
barrows differentially stimulated FSH secretion within 1 h after treatment (Kauffold et al., 
2005). On the other hand, when boars were actively immunized against lGnRH-III, 
concentrations of both LH and FSH were decreased without any evidence of a differential 
regulation of gonadotropin secretion (Bowen et al., 2006). We (Barretero-Hernandez et al., 
2010) also evaluated the effect of infusion (i.v.) of different doses of lGnRH-III on the release 
of LH and FSH in pigs. Barrows were used to evaluate the effect of 0.1, 1.0 or 10.0 µg/kg BW 
of exogenous lGnRH-III on LH and FSH secretion (Figure 7). Blood samples were taken at 
10-min intervals for 6 h, starting 2 h before treatments were applied. Relative concentrations 
of FSH after lGnRH-III infusion did not influence mean concentration of FSH at any of the 
doses; however, 10.0 µg/kg BW had a significant effect on LH secretion. We conclude that 
lGnRH-III is a weak GnRH agonist, and at high doses, lGnRH-III has the ability to release 
LH but not FSH in barrows. Similar findings were also obtained in gilts that were infused 
(i.m.) with a synthetic lGnRH-III product (Brussow et al., 2010).  
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Figure 7. Mean concentrations of LH (A) and FSH (B) in serum at 10-min intervals before and after 
(arrows) 0.1, 1.0 or 10 µg of lGnRH-III were given intravenously. Only a dose of 10 µg/kg BW elicited a 
significant LH increase that was considered to be associated with exogenous lGnRH-III infusion (n = 6 
animals per treatment). Adapted from (Barretero-Hernandez et al., 2010). 
Taken together, the gene expression of lGnRH-III and its receptor has not been reported in 
mammalian species. Although early work in rats, cows and pigs suggested a selective 
release of FSH via lGnRH-III, the bulk of the evidence does not support a contribution of 
lGnRH-III on the selective release of FSH. It is possible that a different peptide (closely 
related to lGnRH-III) may be associated with FSH release. 
Author details 
Jorge Vizcarra 
Alabama A&M University, USA 
 
Gonadotropin 16 
5. References 
Amstalden, M., D. A. Zieba, M. R. Garcia, R. L. Stanko, T. H. Welsh, Jr., W. H. Hansel, and 
G. L. Williams. 2004. Evidence that lamprey GnRH-III does not release FSH selectively 
in cattle. Reproduction 127: 35-43. 
Baird, D. T., B. K. Campbell, G. E. Mann, and A. S. McNeilly. 1991. Inhibin and oestradiol in 
the control of FSH secretion in the sheep. Journal of Reproduction and Fertility 43: 125-
138. 
Barb, C. R., R. R. Kraeling, and G. B. Rampacek. 2001. Nutritional regulators of the 
hypothalamic-pituitary axis in pigs. Reproduction (Cambridge, England) Supplement 
58: 1-15. 
Barran, P. E., R. W. Roeske, A. J. Pawson, R. Sellar, M. T. Bowers, K. Morgan, Z. L. Lu, M. 
Tsuda, T. Kusakabe, and R. P. Millar. 2005. Evolution of constrained gonadotropin-
releasing hormone ligand conformation and receptor selectivity. J Biol Chem 280: 38569-
38575. 
Barretero-Hernandez, R., J. A. Vizcarra, A. Bowen, and M. Galyean. 2010. Lamprey GnRH-
III releases luteinizing hormone but not follicle stimulating hormone in pigs. 
Reproduction in Domestic Animals 45: 983-987. 
Blomenrohr, M., A. Heding, R. Sellar, R. Leurs, J. Bogerd, K. A. Eidne, and G. B. Willars. 
1999. Pivotal role for the cytoplasmic carboxyl-terminal tail of a nonmammalian 
gonadotropin-releasing hormone receptor in cell surface expression, ligand binding, 
and receptor phosphorylation and internalization. Molecular Pharmacology 56: 1229-
1237. 
Bowen, A., S. Khan, L. Berghman, J. D. Kirby, R. P. Wettemann, and J. A. Vizcarra. 2006. 
Immunization of pigs against chicken gonadotropin-releasing hormone-II and lamprey 
gonadotropin-releasing hormone-III: effects on gonadotropin secretion and testicular 
function. Journal of Animal Science 84: 2990-2999. 
Brussow, K. P., F. Schneider, A. Tuchscherer, and W. Kanitz. 2010. Influence of synthetic 
lamprey GnRH-III on gonadotropin release and steroid hormone levels in gilts. 
Theriogenology 74: 1570-1578. 
Cabrera-Vera, T. M., J. Vanhauwe, T. O. Thomas, M. Medkova, A. Preininger, M. R. 
Mazzoni, and H. E. Hamm. 2003. Insights into G protein structure, function, and 
regulation. Endocrine Reviews 24: 765-781. 
Chou, H. F., and A. L. Johnson. 1987. Luteinizing hormone secretion from anterior pituitary 
cells of the cockerel: evidence for an ultradian rhythm. Poultry Science 66: 732-740. 
Clarke, I. J. 2002. Two decades of measuring GnRH secretion. Reproduction (Cambridge, 
England) Supplement 59: 1-13. 
Culler, M. D., and A. Negro-Vilar. 1987. Pulsatile follicle-stimulating hormone secretion is 
independent of luteinizing hormone-releasing hormone (LHRH): pulsatile replacement 
of LHRH bioactivity in LHRH-immunoneutralized rats. Endocrinology 120: 2011-2021. 
Dees, W. L., J. K. Hiney, S. A. Sower, W. H. Yu, and S. M. McCann. 1999. Localization of 
immunoreactive lamprey gonadotropin-releasing hormone in the rat brain. Peptides 20: 
1503-1511. 
 
Contribution of Chicken GnRH-II and Lamprey GnRH-III on Gonadotropin Secretion 17 
Dees, W. L., R. K. Dearth, R. N. Hooper, S. P. Brinsko, J. E. Romano, H. Rahe, W. H. Yu, and 
S. M. McCann. 2001. Lamprey gonadotropin-releasing hormone-III selectively releases 
follicle stimulating hormone in the bovine. Domest Anim Endocrinol 20: 279-288. 
Dellovade, T. L., J. A. King, R. P. Millar, and E. F. Rissman. 1993. Presence and differential 
distribution of distinct forms of immunoreactive gonadotropin-releasing hormone in 
the musk shrew brain. Neuroendocrinology 58: 166-177. 
Densmore, V. S., and H. F. Urbanski. 2003. Relative effect of gonadotropin-releasing 
hormone (GnRH)-I and GnRH-II on gonadotropin release. The Journal of Clinical 
Endocrinology and Metabolism 88: 2126-2134. 
Densmore, V., and H. Urbanski. 2004. Effect of 17beta-estradiol on hypothalamic GnRH-II 
gene expression in the female rhesus macaque. Journal of Molecular Endocrinology 33: 
145-153. 
DePaolo, L. V., T. A. Bicsak, G. F. Erickson, S. Shimasaki, and N. Ling. 1991. Follistatin and 
activin: a potential intrinsic regulatory system within diverse tissues. Proceedings of the 
Society for Experimental Biology and Medicine. Society for Experimental Biology and 
Medicine New York, N.Y 198: 500-512. 
Desaulniers, A. T., A. M. Voss, R. A. Cederberg, C. Lee, G. A. Mills, M. D. Snyder, and B. R. 
White. 2011. 6 Production of gonadotropin-releasing hormone II receptor knockdown 
swine. Reproduction, Fertility and Development 24: 114-114. 
El Majdoubi, M., A. Sahu, and T. M. Plant. 1998. Effect of estrogen on hypothalamic 
transforming growth factor alpha and gonadotropin-releasing hormone gene 
expression in the female rhesus monkey. Neuroendocrinology 67: 228-235. 
Esbenshade, K. L., A. J. Ziecik, and J. H. Britt. 1990. Regulation and action of gonadotrophins 
in pigs. Journal of Reproduction and Fertility 40: 19-32. 
Fister, S., A. R. Gunthert, G. Emons, and C. Grundker. 2007. Gonadotropin-releasing 
hormone type II antagonists induce apoptotic cell death in human endometrial and 
ovarian cancer cells in vitro and in vivo. Cancer Research 67: 1750-1756. 
Gautron, J. P., C. Gras, and A. Enjalbert. 2005. Molecular polymorphism of native 
gonadotropin-releasing hormone (GnRH) is restricted to mammalian GnRH and 
[hydroxyproline9] GnRH in the developing rat brain. Neuroendocrinology 81: 69-86. 
Guillemin, R., and B. Rosenberg. 1955. Humoral hypothalamic control of anterior pituitary: a 
study with combined tissue cultures. Endocrinology 57: 599-607. 
Guillemin, R. 2005. Hypothalamic hormones a.k.a. hypothalamic releasing factors. J 
Endocrinol 184: 11-28. 
Harris, G. W. 1948. Neural control of the pituitary gland. Physiological Reviews 28: 139-179. 
Hattori, A., S. Ishii, and M. Wada. 1986. Effects of two kinds of chicken luteinizing hormone-
releasing hormone (LH-RH), mammalian LH-RH and its analogs on the release of LH 
and FSH in Japanese quail and chicken. Gen Comp Endocrinol 64: 446-455. 
Herbst, K. L. 2003. Gonadotropin-releasing hormone antagonists. Current Opinion in 
Pharmacology 3: 660-666. 
Heredi-Szabo, K., R. F. Murphy, and S. Lovas. 2006. Is lGnRH-III the most potent GnRH 
analog containing only natural amino acids that specifically inhibits the growth of 
human breast cancer cells? Journal of Peptide Science. 12: 714-720. 
 
Gonadotropin 18 
Hiney, J. K., S. A. Sower, W. H. Yu, S. M. McCann, and W. L. Dees. 2002. Gonadotropin-
releasing hormone neurons in the preoptic-hypothalamic region of the rat contain 
lamprey gonadotropin-releasing hormone III, mammalian luteinizing hormone-
releasing hormone, or both peptides. Proceedings of the National Academy of Sciences 
of the United States of America 99: 2386-2391. 
Huirne, J. A., and C. B. Lambalk. 2001. Gonadotropin-releasing-hormone-receptor 
antagonists. Lancet 358: 1793-1803. 
Igarashi, M., and S. M. McCann. 1964. A Hypothalamic Follicle Stimulating Hormone-
Releasing Factor. Endocrinology 74: 446-452. 
Ikemoto, T., and M. K. Park. 2006. Comparative genomics of the endocrine systems in 
humans and chimpanzees with special reference to GNRH2 and UCN2 and their 
receptors. Genomics 87: 459-462. 
Kaiser, U. B., P. M. Conn, and W. W. Chin. 1997. Studies of gonadotropin-releasing hormone 
(GnRH) action using GnRH receptor-expressing pituitary cell lines. Endocrine Reviews 
18: 46-70. 
Kakar, S. S., L. C. Musgrove, D. C. Devor, J. C. Sellers, and J. D. Neill. 1992. Cloning, 
sequencing, and expression of human gonadotropin releasing hormone (GnRH) 
receptor. Biochem Biophys Res Commun 189: 289-295. 
Katz, I. A., R. P. Millar, and J. A. King. 1990. Differential regional distribution and release of 
two forms of gonadotropin-releasing hormone in the chicken brain. Peptides 11: 443-
450. 
Kauffman, A. S., and E. F. Rissman. 2004a. A critical role for the evolutionarily conserved 
gonadotropin-releasing hormone II: mediation of energy status and female sexual 
behavior. Endocrinology 145: 3639-3646. 
Kauffman, A. S., and E. F. Rissman. 2004b. The evolutionarily conserved gonadotropin-
releasing hormone II modifies food intake. Endocrinology 145: 686-691. 
Kauffman, A. S., A. Wills, R. P. Millar, and E. F. Rissman. 2005. Evidence that the type-2 
gonadotrophin-releasing hormone (GnRH) receptor mediates the behavioural effects of 
GnRH-II on feeding and reproduction in musk shrews. Journal of Neuroendocrinology 
17: 489-497. 
Kauffman, A. S., K. Bojkowska, A. Wills, and E. F. Rissman. 2006. Gonadotropin-releasing 
hormone-II messenger ribonucleic acid and protein content in the mammalian brain are 
modulated by food intake. Endocrinology 147: 5069-5077. 
Kauffold, J., F. Schneider, W. Zaremba, and K. P. Brussow. 2005. Lamprey GnRH-III 
stimulates FSH secretion in barrows. Reproduction in Domestic Animals 40: 475-479. 
Kim, D. K., J. S. Yang, K. Maiti, J. I. Hwang, K. Kim, D. Seen, Y. Ahn, C. Lee, B. C. Kang, H. 
B. Kwon, J. Cheon, and J. Y. Seong. 2009. A gonadotropin-releasing hormone-II 
antagonist induces autophagy of prostate cancer cells. Cancer Research 69: 923-931. 
Kim, D. K., E. B. Cho, M. J. Moon, S. Park, J. I. Hwang, O. Kah, S. A. Sower, H. Vaudry, and 
J. Y. Seong. 2011. Revisiting the evolution of gonadotropin-releasing hormones and 
their receptors in vertebrates: secrets hidden in genomes. Gen Comp Endocrinol 170: 68-
78. 
 
Contribution of Chicken GnRH-II and Lamprey GnRH-III on Gonadotropin Secretion 19 
King, J. A., and R. P. Millar. 1982. Structure of chicken hypothalamic luteinizing hormone-
releasing hormone. II. Isolation and characterization. J Biol Chem 257: 10729-10732. 
King, J. A., and R. P. Millar. 1995. Evolutionary aspects of gonadotropin-releasing hormone 
and its receptor. Cell Mol Neurobiol 15: 5-23. 
Kovacs, M., J. Seprodi, M. Koppan, J. E. Horvath, B. Vincze, I. Teplan, and B. Flerko. 2002. 
Lamprey gonadotropin hormone-releasing hormone-III has no selective follicle-
stimulating hormone-releasing effect in rats. Journal of Neuroendocrinology 14: 647-
655. 
Krishnan, K. A., J. A. Proudman, D. J. Bolt, and J. M. Bahr. 1993. Development of an 
homologous radioimmunoassay for chicken follicle-stimulating hormone and 
measurement of plasma FSH during the ovulatory cycle. Comp Biochem Physiol Comp 
Physiol 105: 729-734. 
Latimer, V. S., S. G. Kohama, V. T. Garyfallou, and H. F. Urbanski. 2001. A developmental 
increase in the expression of messenger ribonucleic acid encoding a second form of 
gonadotropin-releasing hormone in the rhesus macaque hypothalamus. The Journal of 
Clinical Endocrinology and Metabolism 86: 324-329. 
Lescheid, D. W., E. Terasawa, L. A. Abler, H. F. Urbanski, C. M. Warby, R. P. Millar, and N. 
M. Sherwood. 1997. A second form of gonadotropin-releasing hormone (GnRH) with 
characteristics of chicken GnRH-II is present in the primate brain. Endocrinology 138: 
5618-5629. 
Lovas, S., I. Palyi, B. Vincze, J. Horvath, M. Kovacs, I. Mezo, G. Toth, I. Teplan, and R. F. 
Murphy. 1998. Direct anticancer activity of gonadotropin-releasing hormone-III. J Pept 
Res 52: 384-389. 
Lumpkin, M. D., J. H. Moltz, W. H. Yu, W. K. Samson, and S. M. McCann. 1987. Purification 
of FSH-releasing factor: its dissimilarity from LHRH of mammalian, avian, and piscian 
origin. Brain Research Bulletin 18: 175-178. 
Lumpkin, M. D., J. K. McDonald, W. K. Samson, and S. M. McCann. 1989. Destruction of the 
dorsal anterior hypothalamic region suppresses pulsatile release of follicle stimulating 
hormone but not luteinizing hormone. Neuroendocrinology 50: 229-235. 
Maiti, K., J. H. Li, A. F. Wang, S. Acharjee, W. P. Kim, W. B. Im, H. B. Kwon, and J. Y. Seong. 
2003. GnRH-II analogs for selective activation and inhibition of non-mammalian and 
type-II mammalian GnRH receptors. Molecules and Cells 16: 173-179. 
Maney, D. L., R. D. Richardson, and J. C. Wingfield. 1997. Central administration of chicken 
gonadotropin-releasing hormone-II enhances courtship behavior in a female sparrow. 
Hormones and Behavior 32: 11-18. 
Marubayashi, U., W. H. Yu, and S. M. McCann. 1999. Median eminence lesions reveal 
separate hypothalamic control of pulsatile follicle-stimulating hormone and luteinizing 
hormone release. Proceedings of the Society for Experimental Biology and Medicine. 
Society for Experimental Biology and Medicine. New York, N.Y 220: 139-146. 
Mather, J. P., T. K. Woodruff, and L. A. Krummen. 1992. Paracrine regulation of 
reproductive function by inhibin and activin. Proceedings of the Society for 
Experimental Biology and Medicine. Society for Experimental Biology and Medicine. 
New York, N.Y 201: 1-15. 
 
Gonadotropin 20 
Matsuo, H., Y. Baba, R. M. Nair, A. Arimura, and A. V. Schally. 1971. Structure of the 
porcine LH- and FSH-releasing hormone. I. The proposed amino acid sequence. 
Biochem Biophys Res Commun 43: 1334-1339. 
McCann, S. M., and A. Fruit. 1957. Effect of synthetic vasopressin on release of 
adrenocorticotrophin in rats with hypothalamic lesions. Proceedings of the Society for 
Experimental Biology and Medicine. Society for Experimental Biology and Medicine. 
New York, N.Y 96: 566-567. 
McCann, S. M., H. Mizunuma, W. K. Samson, and M. D. Lumpkin. 1983. Differential 
hypothalamic control of FSH secretion: a review. Psychoneuroendocrinology 8: 299-308. 
McCann, S. M., S. Karanth, C. A. Mastronardi, W. L. Dees, G. Childs, B. Miller, S. Sower, and 
W. H. Yu. 2001. Control of Gonadotropin Secretion by Follicle-Stimulating Hormone-
Releasing Factor, Luteinizing Hormone-Releasing Hormone, and Leptin. Archives of 
Medical Research 32: 476-485. 
McCann, S. M., and W. H. Yu. 2001. FSH-releasing peptides. US Patent 6,300,471. 
McCann, S. M., S. Karanth, C. A. Mastronardi, W. L. Dees, G. Childs, B. Miller, S. Sower, and 
W. H. Yu. 2002. Hypothalamic control of gonadotropin secretion. Progress in Brain 
Research 141: 151-164. 
Meddle, S. L., S. Bush, P. J. Sharp, R. P. Millar, and J. C. Wingfield. 2006. Hypothalamic pro-
GnRH-GAP, GnRH-I and GnRH-II during the onset of photorefractoriness in the white-
crowned sparrow (Zonotrichia leucophrys gambelii). Journal of Neuroendocrinology 
18: 217-226. 
Mezo, I., S. Lovas, I. Palyi, B. Vincze, A. Kalnay, G. Turi, Z. Vadasz, J. Seprodi, M. Idei, G. 
Toth, E. Gulyas, F. Otvos, M. Mak, J. E. Horvath, I. Teplan, and R. F. Murphy. 1997. 
Synthesis of gonadotropin-releasing hormone III analogs. Structure-antitumor activity 
relationships. Journal of Medicinal Chemistry 40: 3353-3358. 
Millar, R. P., and J. A. King. 1987. Structural and functional evolution of gonadotropin-
releasing hormone. International Review of Cytology 106: 149-182. 
Millar, R., D. Conklin, C. Lofton-Day, E. Hutchinson, B. Troskie, N. Illing, S. C. Sealfon, and 
J. Hapgood. 1999. A novel human GnRH receptor homolog gene: abundant and wide 
tissue distribution of the antisense transcript. J Endocrinol 162: 117-126. 
Millar, R., S. Lowe, D. Conklin, A. Pawson, S. Maudsley, B. Troskie, T. Ott, M. Millar, G. 
Lincoln, R. Sellar, B. Faurholm, G. Scobie, R. Kuestner, E. Terasawa, and A. Katz. 2001. 
A novel mammalian receptor for the evolutionarily conserved type II GnRH. 
Proceedings of the National Academy of Sciences of the United States of America 98: 
9636-9641. 
Millar, R. P. 2003. GnRH II and type II GnRH receptors. Trends in Endocrinology and 
Metabolism: TEM 14: 35-43. 
Millar, R. P., Z. L. Lu, A. J. Pawson, C. A. Flanagan, K. Morgan, and S. R. Maudsley. 2004. 
Gonadotropin-releasing hormone receptors. Endocrine Reviews 25: 235-275. 
Millar, R. P. 2005. GnRHs and GnRH receptors. Anim Reprod Sci 88: 5-28. 
Millar, R. P., A. J. Pawson, K. Morgan, E. F. Rissman, and Z. L. Lu. 2008. Diversity of actions 
of GnRHs mediated by ligand-induced selective signaling. Frontiers in 
Neuroendocrinology 29: 17-35. 
 
Contribution of Chicken GnRH-II and Lamprey GnRH-III on Gonadotropin Secretion 21 
Millar, R. P., and C. L. Newton. 2010. The year in G protein-coupled receptor research. 
Molecular Endocrinology Baltimore, Md 24: 261-274. 
Miyamoto, K., Y. Hasegawa, T. Minegishi, M. Nomura, Y. Takahashi, M. Igarashi, K. 
Kangawa, and H. Matsuo. 1982. Isolation and characterization of chicken hypothalamic 
luteinizing hormone-releasing hormone. Biochem Biophys Res Commun 107: 820-827. 
Miyamoto, K., Y. Hasegawa, M. Nomura, M. Igarashi, K. Kangawa, and H. Matsuo. 1984. 
Identification of the second gonadotropin-releasing hormone in chicken hypothalamus: 
evidence that gonadotropin secretion is probably controlled by two distinct 
gonadotropin-releasing hormones in avian species. Proceedings of the National 
Academy of Sciences of the United States of America 81: 3874-3878. 
Montaner, A. D., J. M. Affanni, J. A. King, J. J. Bianchini, G. Tonarelli, and G. M. Somoza. 
1999. Differential distribution of gonadotropin-releasing hormone variants in the brain 
of Hydrochaeris hydrochaeris (Mammalia, Rodentia). Cell Mol Neurobiol 19: 635-651. 
Montaner, A. D., L. Mongiat, V. A. Lux-Lantos, M. K. Park, W. H. Fischer, A. G. Craig, J. E. 
Rivier, D. Lescheid, D. Lovejoy, C. Libertun, N. M. Sherwood, and G. M. Somoza. 2001. 
Structure and biological activity of gonadotropin-releasing hormone isoforms isolated 
from rat and hamster brains. Neuroendocrinology 74: 202-212. 
Moran, F. M., J. J. Ford, C. J. Corbin, S. M. Mapes, V. C. Njar, A. M. Brodie, and A. J. Conley. 
2002. Regulation of microsomal P450, redox partner proteins, and steroidogenesis in the 
developing testes of the neonatal pig. Endocrinology 143: 3361-3369. 
Morgan, K., R. Sellar, A. J. Pawson, Z. L. Lu, and R. P. Millar. 2006. Bovine and ovine 
gonadotropin-releasing hormone (GnRH)-II ligand precursors and type II GnRH 
receptor genes are functionally inactivated. Endocrinology 147: 5041-5051. 
Neill, J. D. 2002. GnRH and GnRH receptor genes in the human genome. Endocrinology 143: 
737-743. 
Neill, J. D., L. W. Duck, and L. C. Musgrove. 2002. Potential regulatory role for GnRH II in 
gonadotropin secretion: molecular characterization of a GnRH II receptor from pig 
pituitary. Proceedings of the Society for Neuroscience Abstract 74.9. 
Neill, J. D., L. C. Musgrove, and L. W. Duck. 2004. Newly recognized GnRH receptors: 
function and relative role. Trends in Endocrinology and Metabolism: TEM 15: 383-392. 
Nett, T. M., A. M. Turzillo, M. Baratta, and L. A. Rispoli. 2002. Pituitary effects of steroid 
hormones on secretion of follicle-stimulating hormone and luteinizing hormone. 
Domest Anim Endocrinol 23: 33-42. 
Okada, Y., A. Murota-Kawano, S. S. Kakar, and S. J. Winters. 2003. Evidence that 
gonadotropin-releasing hormone (GnRH) II stimulates luteinizing hormone and follicle-
stimulating hormone secretion from monkey pituitary cultures by activating the GnRH 
I receptor. Biology of Reproduction 69: 1356-1361. 
Padmanabhan, V., K. McFadden, D. T. Mauger, F. J. Karsch, and A. R. Midgley, Jr. 1997. 
Neuroendocrine control of follicle-stimulating hormone (FSH) secretion. I. Direct 
evidence for separate episodic and basal components of FSH secretion. Endocrinology 
138: 424-432. 
Padmanabhan, V., and A. S. McNeilly. 2001. Is there an FSH-releasing factor? Reproduction 
121: 21-30. 
 
Gonadotropin 22 
Padmanabhan, V., F. J. Karsch, and J. S. Lee. 2002. Hypothalamic, pituitary and gonadal 
regulation of FSH. Reproduction (Cambridge, England) Supplement 59: 67-82. 
Palyi, I., B. Vincze, S. Lovas, I. Mezo, J. Pato, A. Kalnay, G. Turi, D. Gaal, R. Mihalik, I. Peter, 
I. Teplan, and R. F. Murphy. 1999. Gonadotropin-releasing hormone analogue 
conjugates with strong selective antitumor activity. Proceedings of the National 
Academy of Sciences of the United States of America 96: 2361-2366. 
Pawson, A. J., S. Maudsley, K. Morgan, L. Davidson, Z. Naor, and R. P. Millar. 2005. 
Inhibition of human type i gonadotropin-releasing hormone receptor (GnRHR) function 
by expression of a human type II GnRHR gene fragment. Endocrinology 146: 2639-2649. 
Perfito, N., R. Zann, T. Ubuka, G. Bentley, and M. Hau. 2011. Potential roles for GNIH and 
GNRH-II in reproductive axis regulation of an opportunistically breeding songbird. 
Gen Comp Endocrinol 173: 20-26. 
Powell, J. F., Y. Zohar, A. Elizur, M. Park, W. H. Fischer, A. G. Craig, J. E. Rivier, D. A. 
Lovejoy, and N. M. Sherwood. 1994. Three forms of gonadotropin-releasing hormone 
characterized from brains of one species. Proceedings of the National Academy of 
Sciences of the United States of America 91: 12081-12085. 
Rastogi, R. K., D. L. Meyer, C. Pinelli, M. Fiorentino, and B. D'Aniello. 1998. Comparative 
analysis of GnRH neuronal systems in the amphibian brain. Gen Comp Endocrinol 112: 
330-345. 
Rissman, E. F., and X. Li. 1998. Sex differences in mammalian and chicken-II gonadotropin-
releasing hormone immunoreactivity in musk shrew brain. Gen Comp Endocrinol 112: 
346-355. 
Roch, G. J., E. R. Busby, and N. M. Sherwood. 2011. Evolution of GnRH: diving deeper. Gen 
Comp Endocrinol 171: 1-16. 
Rumsfeld, H. W., Jr., and J. C. Porter. 1962. ACTH-releasing activity of bovine posterior 
pituitaries. Endocrinology 70: 62-67. 
Saffran, M., A. V. Schally, and B. G. Benfey. 1955. Stimulation of the release of corticotropin 
from the adenohypophysis by a neurohypophysial factor. Endocrinology 57: 439-444. 
Schally, A. V., A. Arimura, A. J. Kastin, H. Matsuo, Y. Baba, T. W. Redding, R. M. Nair, L. 
Debeljuk, and W. F. White. 1971. Gonadotropin-releasing hormone: one polypeptide 
regulates secretion of luteinizing and follicle-stimulating hormones. Science 173: 1036-
1038. 
Schally, A. V. 2000. Use of GnRH in preference to LH-RH terminology in scientific papers. 
Human Reproduction 15: 2059-2061. 
Schally, A. V., A. M. Comaru-Schally, A. Nagy, M. Kovacs, K. Szepeshazi, A. Plonowski, J. L. 
Varga, and G. Halmos. 2001. Hypothalamic hormones and cancer. Frontiers in 
neuroendocrinology 22: 248-291. 
Sealfon, S. C., H. Weinstein, and R. P. Millar. 1997. Molecular mechanisms of ligand 
interaction with the gonadotropin-releasing hormone receptor. Endocrine Reviews 18: 
180-205. 
Sharp, P. J., and C. B. Gow. 1983. Neuroendocrine control of reproduction in the cockerel. 
Poultry Science 62: 1671-1675. 
 
Contribution of Chicken GnRH-II and Lamprey GnRH-III on Gonadotropin Secretion 23 
Sharp, P. J., R. T. Talbot, G. M. Main, I. C. Dunn, H. M. Fraser, and N. S. Huskisson. 1990. 
Physiological roles of chicken LHRH-I and -II in the control of gonadotrophin release in 
the domestic chicken. J Endocrinol 124: 291-299. 
Silver, M. R., N. V. Nucci, A. R. Root, K. L. Reed, and S. A. Sower. 2005. Cloning and 
characterization of a functional type II gonadotropin-releasing hormone receptor with a 
lengthy carboxy-terminal tail from an ancestral vertebrate, the sea lamprey. 
Endocrinology 146: 3351-3361. 
Silver, M. R., and S. A. Sower. 2006. Functional characterization and kinetic studies of an 
ancestral lamprey GnRH-III selective type II GnRH receptor from the sea lamprey, 
Petromyzon marinus. J Mol Endocrinol 36: 601-610. 
Skinner, D. C., A. J. Albertson, A. Navratil, A. Smith, M. Mignot, H. Talbott, and N. Scanlan-
Blake. 2009. Effects of gonadotrophin-releasing hormone outside the hypothalamic-
pituitary-reproductive axis. Journal of Neuroendocrinology 21: 282-292. 
Sower, S. A., Y. C. Chiang, S. Lovas, and J. M. Conlon. 1993. Primary structure and biological 
activity of a third gonadotropin-releasing hormone from lamprey brain. Endocrinology 
132: 1125-1131. 
Spies, H. G., R. L. Norman, S. K. Quadri, and D. K. Clifton. 1977. Effects of estradiol-17beta 
on the induction of gonadotropin release by electrical stimulation of the hypothalamus 
in rhesus monkeys. Endocrinology 100: 314-324. 
Stevenson, T. J., G. E. Bentley, T. Ubuka, L. Arckens, E. Hampson, and S. A. MacDougall-
Shackleton. 2008. Effects of social cues on GnRH-I, GnRH-II, and reproductive 
physiology in female house sparrows (Passer domesticus). Gen Comp Endocrinol 156: 
385-394. 
Stewart, A. J., A. A. Katz, R. P. Millar, and K. Morgan. 2009. Retention and silencing of 
prepro-GnRH-II and type II GnRH receptor genes in mammals. Neuroendocrinology 
90: 416-432. 
Temple, J. L., R. P. Millar, and E. F. Rissman. 2003. An evolutionarily conserved form of 
gonadotropin-releasing hormone coordinates energy and reproductive behavior. 
Endocrinology 144: 13-19. 
Tostivint, H. 2011. Evolution of the gonadotropin-releasing hormone (GnRH) gene family in 
relation to vertebrate tetraploidizations. Gen Comp Endocrinol 170: 575-581. 
Tsutsumi, M., W. Zhou, R. P. Millar, P. L. Mellon, J. L. Roberts, C. A. Flanagan, K. Dong, B. 
Gillo, and S. C. Sealfon. 1992. Cloning and functional expression of a mouse 
gonadotropin-releasing hormone receptor. Molecular Endocrinology Baltimore, Md 6: 
1163-1169. 
Urbanski, H. F., R. B. White, R. D. Fernald, S. G. Kohama, V. T. Garyfallou, and V. S. 
Densmore. 1999. Regional expression of mRNA encoding a second form of 
gonadotropin-releasing hormone in the macaque brain. Endocrinology 140: 1945-1948. 
Vizcarra, J. A., R. P. Wettemann, T. D. Braden, A. M. Turzillo, and T. M. Nett. 1997. Effect of 
gonadotropin-releasing hormone (GnRH) pulse frequency on serum and pituitary 
concentrations of luteinizing hormone and follicle-stimulating hormone, GnRH 
receptors, and messenger ribonucleic acid for gonadotropin subunits in cows. 
Endocrinology 138: 594-601. 
 
Gonadotropin 24 
Vizcarra, J., M. Rhoads, C. Hsu, J. Washington, J. Morgan, J. Yang, H. Tang, J. Warren, and J. 
Kirby. 2000. Effect of immunization against chicken gonadotropin releasing hormone –I 
(cGnRH-I) and cGnRH-II on reproductive function in adult broiler breeder males. 
Poultry Sci 79: Abs 343. 
Vizcarra, J. A., D. L. Kreider, and J. D. Kirby. 2004. Episodic gonadotropin secretion in the 
mature fowl: serial blood sampling from unrestrained male broiler breeders (Gallus 
domesticus). Biology of Reproduction 70: 1798-1805. 
Vizcarra, J. A., S. L. Karges, and R. P. Wettemann. 2012. Immunization of beef heifers against 
gonadotropin-releasing hormone prevents luteal activity and pregnancy: effect of 
conjugation to different proteins and effectiveness of adjuvants. Journal of Animal 
Science (In Press). 
Wade, N. 1978. Guillemin and Schally: The Years in the Wilderness. Science 200: 279-282. 
Weesner, G. D., and R. L. Matteri. 1994. Rapid communication: nucleotide sequence of 
luteinizing hormone-releasing hormone (LHRH) receptor cDNA in the pig pituitary. 
Journal of Animal Science 72: 1911. 
Wilson, S. C., and P. J. Sharp. 1975. Episodic release of luteinizing hormone in the domestic 
fowl. J Endocrinol 64: 77-86. 
Wise, T., E. L. Zanella, D. D. Lunstra, and J. J. Ford. 2000. Relationships of gonadotropins, 
testosterone, and cortisol in response to GnRH and GnRH antagonist in boars selected 
for high and low follicle-stimulating hormone levels. Journal of Animal Science 78: 
1577-1590. 
Yahalom, D., A. Chen, N. Ben-Aroya, S. Rahimipour, E. Kaganovsky, E. Okon, M. Fridkin, 
and Y. Koch. 1999. The gonadotropin-releasing hormone family of neuropeptides in the 
brain of human, bovine and rat: identification of a third isoform. FEBS Lett 463: 289-294. 
Yu, W. H., S. Karanth, A. Walczewska, S. A. Sower, and S. M. McCann. 1997. A 
hypothalamic follicle-stimulating hormone-releasing decapeptide in the rat. 
Proceedings of the National Academy of Sciences of the United States of America 94: 
9499-9503. 
Yu, W. H., S. Karanth, S. A. Sower, A. F. Parlow, and S. M. McCann. 2000. The similarity of 
FSH-releasing factor to lamprey gonadotropin-releasing hormone III (l-GnRH-III). 
Proceedings of the Society for Experimental Biology and Medicine. Society for 
Experimental Biology and Medicine New York, N.Y 224: 87-92. 
Yu, W. H., S. Karanth, C. A. Mastronardi, S. Sealfon, C. Dean, W. L. Dees, and S. M. 
McCann. 2002. Lamprey GnRH-III acts on its putative receptor via nitric oxide to 
release follicle-stimulating hormone specifically. Experimental Biology and Medicine 
Maywood, N.J 227: 786-793. 
Zanella, E. L., D. D. Lunstra, T. H. Wise, J. E. Kinder, and J. J. Ford. 2000. GnRH antagonist 
inhibition of gonadotropin and steroid secretion in boars in vivo and steroid production 
in vitro. Journal of Animal Science 78: 1591-1597. 
Ziecik, A. J., K. L. Esbenshade, and J. H. Britt. 1989. Effects of a gonadotrophin-releasing 
hormone antagonist on gonadotrophin secretion and gonadal development in neonatal 
pigs. J Reprod Fertil 87: 281-289. 
